Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population

Area of Science:

• Immunology
• Cell Biology

Background:

• CD4(+)CD25(+) T cells, known for immune suppression in animals, have not been definitively identified in humans.
• Understanding human regulatory T cells is crucial for immune system research.

Purpose of the Study:

• To identify and characterize a human CD4(+)CD25(+) T cell subset.
• To investigate the suppressive function and characteristics of these human regulatory T cells.

Main Methods:

• Flow cytometry and cell sorting to isolate CD4(+)CD25(+) T cells from human peripheral blood and tonsils.
• In vitro proliferation assays to assess the impact of CD4(+)CD25(+) T cells on CD4(+)CD25(-) T cell activity.
• Cytokine blocking experiments and apoptosis assays (Bcl-2 expression) to elucidate mechanisms of suppression and cell death.

Main Results:

• A distinct human CD4(+)CD25(+) T cell subset (7-10% of CD4(+) T cells) was identified as CD45RO(+)CD45RB(low), indicating a highly differentiated state.
• These cells exhibited anergy to stimulation and significantly suppressed proliferation of CD4(+)CD25(-) T cells in a cell-contact dependent manner, independent of IL-4, IL-10, or TGF-beta.
• The CD4(+)CD25(+) T cells were apoptosis-prone due to low Bcl-2 expression, but this could be rescued by IL-2 or IFN-beta, without altering their suppressive function.

Conclusions:

• A naturally occurring, highly suppressive, and apoptosis-prone human CD4(+)CD25(+) T cell population at a late differentiation stage has been characterized.
• These findings underscore the importance of these regulatory T cells in human immune homeostasis and disease.
• Further investigation into their roles in human health and pathology is essential.